Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2006
01/03/2006US6982146 High speed parallel molecular nucleic acid sequencing
01/03/2006US6982143 tagging; comprises dna polymerases/ribonucleases; kits
01/03/2006US6982092 Method of complexing a nucleic acid with a lipid-conjugated polyamide
01/03/2006US6982087 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue
01/03/2006US6982084 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies
01/03/2006US6982083 Starch granules containing a recombinant polypeptide of interest, method for obtaining them, and their uses
01/03/2006CA2185350C Acridone-derived bisintercalators as chemotherapeutic agents
01/03/2006CA2158937C Recombinant alphavirus vectors
01/03/2006CA2136622C Phosphotriester-type biologically active compounds
01/03/2006CA2070979C Sequence specific dna binding by p53
12/2005
12/29/2005WO2005123958A2 Cd7 as biomarker and therapeutic target for psoriasis
12/29/2005WO2005123929A2 Plastid transit peptides
12/29/2005WO2005123919A1 Plant polynucleotide promoter sequences from lolium festuca and arabidopsis
12/29/2005WO2005123756A1 A method of diagnosing fiv
12/29/2005WO2005122675A2 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proetins
12/29/2005WO2005105995A3 RNA INTERFERENCE MEDIATED TREATMENT OF POLYGLUTAMINE (POLYQ) REPEAT EXPANSION DISEASES USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/29/2005WO2005098448A3 Method and biomarkers for detecting tumor endothelial cell proliferation
12/29/2005WO2005086654A3 Self-cleaving affinity tags and methods of use
12/29/2005WO2005074436A3 Self-assembling split-fluorescent protein systems
12/29/2005WO2005072364A3 A modified baculovirus expression system for production of pseudotyped raav vector
12/29/2005WO2005072092A3 Systems for tightly regulated gene expression
12/29/2005WO2005065309A3 Lentiviral vector delivery of native and mutated igfbp-3 for treatment of cancer
12/29/2005WO2005063802A3 Haemophilus influenzae type iv pili
12/29/2005WO2005053516A3 Replication competent hepatitis c virus and methods of use
12/29/2005WO2005042706A3 Ephx2 genetic markers associated with galantamine response
12/29/2005WO2005042552A3 Modulation of sglt2 expression
12/29/2005WO2005038370A3 Genetic markers for obesity
12/29/2005WO2005034881A3 Methods and compositions for treating conditions involving abnormal angiogenesis
12/29/2005WO2005020889A3 Functional influenza virus-like particles (vlps)
12/29/2005WO2005010204A3 Rapid nucleic acid isolation method and compositions therefore
12/29/2005WO2005004814A3 Sirt1 and genetic disorders
12/29/2005WO2005001043A3 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi
12/29/2005WO2005000098A3 Detection methods for disorders of the lung
12/29/2005WO2004103269A3 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
12/29/2005WO2004035758A3 Rna-based inhibitory oligonucleotides
12/29/2005WO2004013280A3 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
12/29/2005WO2003072799A3 Brother of the regulator of imprinted sites (boris)
12/29/2005WO2003071933A3 Novel compositions and methods for cancer
12/29/2005US20050289670 Plant myo-inositol kinase polynucleotides and methods of use
12/29/2005US20050289669 TTG3 deficient plants, nucleic acids, polypeptides and methods of use thereof
12/29/2005US20050289664 Genes encoding 4-Hydroxyphenylpyruvate dioxygenase (HPPD) enzymes for plant metabolic engineering
12/29/2005US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
12/29/2005US20050288497 Responsiveness to therapy for liver disorders
12/29/2005US20050288487 Human mast cell-expressed membrane proteins
12/29/2005US20050288244 RNA interference; microRNA; improved pharmacokinetics
12/29/2005US20050288243 Methods and compositions for treating gain-of-function disorders using RNA interference
12/29/2005US20050288242 RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)
12/29/2005US20050288241 encoding novel polypeptides, called "NOVX" nucleic acid sequences; vectors and host cells; wide variety of therapeutic and diagnostic uses; drug targets or therapeutic use; encode proteins such as NOV15 of the MEGF/Fibrillin family of proteins which have epidermal growth factor (EGF)-like motifs
12/29/2005US20050288214 Nucleotide sequence encoding PTD and CEA fusion protein, Tat-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein
12/29/2005US20050287647 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
12/29/2005US20050287643 Protein binding miniature proteins and uses thereof
12/29/2005US20050287641 Gene encoding a nonribosomal peptide synthetase for the production of ramoplanin
12/29/2005US20050287639 Methods of incorporating amino acid analogs into proteins
12/29/2005US20050287638 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents
12/29/2005US20050287636 Polypeptide; low density lipoprotein antioxidant, efficient delivery of cholesterol to hepatocytes
12/29/2005US20050287634 Anti-cancer agent
12/29/2005US20050287633 Vanilloid receptor
12/29/2005US20050287631 Compositions and methods related to a dimeric MHC class I and II-Like molecule (dsMHCI and dsMHCII)
12/29/2005US20050287630 Human antibodies derived from immunized xenomice
12/29/2005US20050287628 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
12/29/2005US20050287606 T1 receptor-like ligand I
12/29/2005US20050287587 host cells containing expression systems for production of nucleotide diphosphate 6-deoxy-mycarose; polyketides
12/29/2005US20050287585 In situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, "on device" assembly of larger polynucleotides composed of shorter oligonucleotide fragments
12/29/2005US20050287584 Secreted proteins encoded by human chromosome 13
12/29/2005US20050287582 Antibodies that specifically bind to FDF03
12/29/2005US20050287579 Genes for male accessory gland proteins in Drosophila melanogaster
12/29/2005US20050287570 Probe arrays for expression profiling of rat genes
12/29/2005US20050287569 For therapy and diagnosis of Escherichia coli infections
12/29/2005US20050287568 Novel human transferase proteins and polynucleotides encoding the same
12/29/2005US20050287566 BICYCLIC LOCKED NUCLEOSIDE ANALOGUES; using an oligomer to isolate, purify, amplify, detect, identify, quantify or capture a natural or synthetic nucleic acid
12/29/2005US20050287563 Nucleic acid labeling compounds
12/29/2005US20050287562 Novel human kinase proteins and polynucleotides encoding the same
12/29/2005US20050287558 SNPs of apolipoprotein B and modulation of their expression
12/29/2005US20050287555 Immobilization of nucleotide in microarray; dissolving in ink jet printhead solvent
12/29/2005US20050287548 Activatable probes and methods for in vivo gene detection
12/29/2005US20050287545 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
12/29/2005US20050287543 Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer
12/29/2005US20050287542 Avian pancreatic polypeptide comprising antigenic specificity for use in treatment and prevention of allergies, infection, inflammation, autoimmune and tumor disorders
12/29/2005US20050287538 Preparing a clone for producing an antigen-specific antibody by extracting genomic DNAs of lymphocytes from a mammalian immunized with a specific antigen; recovering variable regions of immunoglobulin, amplifying the variable regions using a frame-shifting PCR
12/29/2005US20050287537 Amino acid modification; improved thermostability, altered substrate specificity, ph optimum and cleavage pattern; economical and efficient
12/29/2005US20050287534 Primers and probe to identify mycobacterium tuberculosis complex
12/29/2005US20050287531 identifying in the nucleic acid sample, a nucleotide occurrence of a single nucleotide polymorphism (SNP) at position 300 of SEQ ID NO:21645, thereby inferring the trait, wherein the trait is marbling, tenderness, fat thickness, red meat yield, or average daily weight gain
12/29/2005US20050287529 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof
12/29/2005US20050287525 bioassay for testing peptides that bind to domain peptides of human immunodeficiency virus type I (HIV-1); peptides used for treating viral diseases
12/29/2005US20050287517 Modulator of sweet or umami taste using ligand binding assay; detecting change in conformation
12/29/2005US20050287170 Subunit vaccine against West Nile viral infection
12/29/2005US20050287165 Meningococcal antigens
12/29/2005US20050287163 Mycoplasma polypeptides
12/29/2005US20050287151 Secreted protein therapeutics and uses thereof
12/29/2005US20050287150 Antibodies against Clostridium difficile toxins and uses thereof
12/29/2005US20050287149 Human monoclonal antibodies against bacillus anthracis protective antigen
12/29/2005US20050287148 Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
12/29/2005US20050287147 Cancer-linked gene as target for chemotherapy
12/29/2005US20050287118 Bacterial plasmid with immunological adjuvant function and uses thereof
12/29/2005US20050287110 Cationic graft-compolymer for non-viral gene delivery vector
12/29/2005US20050287098 Compositions and methods for controlling hair growth
12/29/2005DE102004022574A1 Pharmaceutical formulation, for use in inflammatory disorders, identifies the rabies virus protein P as an interferon antagonist with substitution of the P-coded nucleic acid sequence
12/29/2005CA2735315A1 Plastid transit peptides
12/29/2005CA2734716A1 Plastid transit peptides
12/29/2005CA2734624A1 Plastid transit peptides
1 ... 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 ... 899